ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Ann Thorac Surg 2008;86:1631. doi:10.1016/j.athoracsur.2008.08.055
© 2008 The Society of Thoracic Surgeons
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Frank Detterbeck
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Detterbeck, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Detterbeck, F.
Related Collections
Right arrow Lung - cancer
Right arrowRelated Article

Original Articles: General Thoracic

Invited Commentary

Frank Detterbeck, MD

Division of Thoracic Surgery, Yale University, FMB 128, 330 Cedar St, New Haven, CT 06520-8062

(Email: frank.detterbeck@yale.edu).

The first 20% of the full text of this article appears below.

Misthos and colleagues [1] have performed an interesting retrospective analysis of a fairly large cohort of resected patients who were found to be N2 positive after complete resection. They have confirmed what others have demonstrated: that single station N2 involvement carries a better prognosis than multi-station N2 involvement [2, 3].

This study has several limitations. It is unfortunate that the policy toward preoperative staging is described merely as involving "different means." This is a particular issue because the level of postoperatively discovered N2 disease is one of the highest reported (23%). Moreover, two thirds of these patients had multi-station . . . [Full Text of this Article]


Related Article

The Significance of One-Station N2 Disease in the Prognosis of Patients With Nonsmall-Cell Lung Cancer
Panagiotis Misthos, Evangelos Sepsas, John Kokotsakis, Ion Skottis, and Achilleas Lioulias
Ann. Thorac. Surg. 2008 86: 1626-1630. [Abstract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
S. Cafarotti, A. Cesario, G. Cusumano, and P. Granone
Single Station N2 NSCLC: A Brief Reflection on Possible Overdoing.
Ann. Thorac. Surg., December 1, 2009; 88(6): 2069 - 2070.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 by The Society of Thoracic Surgeons.